More on CNTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (5/7/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Context Therapeutics (NQ:CNTX)
Delayed: 3.12 +0.26 (9.09%)
Prev. Close $2.86  
Open$2.77 
52 Wk High$ 
52 Wk Low$ 
Day High$3.30 
Day Low$2.70 
P/E N/A  
EPS$ 
Volume2,456,738 

Friends, Peers and Foes (?): SMMT, RLAY, SKYE, BNTX, JANX (more...)

Feb 27, 2026 04:14 PM Form 8-K Context Therapeutics For: Feb 24
Feb 23, 2026 04:25 PM Form 4 Context Therapeutics For: Feb 19 Filed by: Levit Alex C.
Feb 23, 2026 04:22 PM Form 4 Context Therapeutics For: Feb 19 Filed by: Minai-Azary Jennifer Lynn
Feb 23, 2026 04:19 PM Form 4 Context Therapeutics For: Feb 19 Filed by: Chagin Karen Deborah
Feb 23, 2026 04:14 PM Form 4 Context Therapeutics For: Feb 19 Filed by: Lehr Martin A.
Feb 17, 2026 04:20 PM Form SCHEDULE 13G/A Context Therapeutics Filed by: GREAT POINT PARTNERS LLC
Feb 17, 2026 04:10 PM Form SCHEDULE 13G/A Context Therapeutics Filed by: MPM BioImpact LLC
Feb 9, 2026 07:30 AM Context Therapeutics to Participate in Upcoming Investor Conferences
Feb 3, 2026 04:42 PM Form SCHEDULE 13G Context Therapeutics Filed by: Soleus Capital Master Fund, L.P.
Jan 16, 2026 04:05 PM Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
View All Articles

Entities mentioned with CNTX

View All Entities